Gwen Knight

Cited by

	All	Since 2019
Citations	4941	4285
h-index	32	29
i10-index	59	55

1100

550

275

825

20132014201520162017201820192020202120222023202419 44 64 115 177 201 294 516 960 1013 915 552

Public access

View all

70 articles

0 articles

available

not available

Based on funding mandates

Co-authors

Richard G WhiteProfessor of Infectious Disease Modelling, London School of Hygiene and Tropical MedicineVerified email at lshtm.ac.uk
Nichola R NaylorOIPPVerified email at oipharmapartners.com
Jodi A. LindsaySt George's, University of LondonVerified email at sgul.ac.uk
Quentin J LeclercPostdoctoral researcher, Institut Pasteur, Conservatoire National des Arts et MétiersVerified email at pasteur.fr
Sebastian FunkProfessor, London School of Hygiene & Tropical MedicineVerified email at lshtm.ac.uk
Rifat AtunProfessor of Global Health Systems, Harvard UniversityVerified email at hsph.harvard.edu
David DowdyProfessor of Epidemiology & Vice Dean for Education, Johns Hopkins Bloomberg School of Public HealthVerified email at jhsph.edu
Naomi M. FullerLondon School of Hygiene and Tropical MedicineVerified email at lshtm.ac.uk
Christopher Finn McQuaidAssociate Professor, London School of Hygiene and Tropical MedicineVerified email at lshtm.ac.uk
Ted CohenDepartment of Epidemiology of Microbial Diseases, Yale School of Public HealthVerified email at yale.edu
Naomi R WaterlowResearch Fellow, London School of Hygiene and Tropical MedicineVerified email at lshtm.ac.uk
Tom SumnerLondon School of Hygiene and Tropical medicineVerified email at lshtm.ac.uk
Pete DoddUniversity of SheffieldVerified email at sheffield.ac.uk
Rein HoubenLondon School of Hygiene and Tropical MedicineVerified email at lshtm.ac.uk
Rebecca E. GloverAssistant Professor of Public Health and Policy, London School of Hygiene and Tropical MedicineVerified email at lshtm.ac.uk
Sarah R. DeenyThe Health FoundationVerified email at health.org.uk
Francesc CollInstitute of Biomedicine of Valencia (IBV), Spanish National Research Council (CSIC)Verified email at ibv.csic.es
Rebecca C HarrisLondon School of Hygiene and Tropical MedicineVerified email at lshtm.ac.uk
Mariam O FofanaYale UniversityVerified email at yale.edu
Timothy D. McHughProfessor of Medical Microbiology, UCLVerified email at ucl.ac.uk

Gwen Knight

Associate Professor, London School of Hygiene and Tropical Medicine

Verified email at lshtm.ac.uk

Mathematical modelling antibiotic resistance TB MRSA Infectious Disease Dynamics


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
COVID-19 length of hospital stay: a systematic review and data synthesis EM Rees, ES Nightingale, Y Jafari, NR Waterlow, S Clifford, ... BMC medicine 18, 1-22, 2020	702	2020
Estimating the burden of antimicrobial resistance: a systematic literature review NR Naylor, R Atun, N Zhu, K Kulasabanathan, S Silva, A Chatterjee, ... Antimicrobial Resistance & Infection Control 7, 1-17, 2018	539	2018
What settings have been linked to SARS-CoV-2 transmission clusters? QJ Leclerc, NM Fuller, LE Knight, S Funk, GM Knight, ... Wellcome open research 5, 2020	436	2020
Antimicrobial resistance and COVID-19: Intersections and implications GM Knight, RE Glover, CF McQuaid, ID Olaru, K Gallandat, QJ Leclerc, ... Elife 10, e64139, 2021	333	2021
The transmission of Mycobacterium tuberculosis in high burden settings TA Yates, PY Khan, GM Knight, JG Taylor, TD McHugh, M Lipman, ... The Lancet infectious diseases 16 (2), 227-238, 2016	237	2016
Impact and cost-effectiveness of new tuberculosis vaccines in low-and middle-income countries GM Knight, UK Griffiths, T Sumner, YV Laurence, A Gheorghe, A Vassall, ... Proceedings of the National Academy of Sciences 111 (43), 15520-15525, 2014	188	2014
Shift in dominant hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) clones over time GM Knight, EL Budd, L Whitney, A Thornley, H Al-Ghusein, T Planche, ... Journal of Antimicrobial Chemotherapy 67 (10), 2514-2522, 2012	171	2012
Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling GM Knight, CF McQuaid, PJ Dodd, RMGJ Houben The Lancet Infectious Diseases 19 (8), 903-912, 2019	164	2019
The complex evolution of antibiotic resistance in Mycobacterium tuberculosis JD Fonseca, GM Knight, TD McHugh International journal of infectious diseases 32, 94-100, 2015	130	2015
The contribution of asymptomatic SARS-CoV-2 infections to transmission on the Diamond Princess cruise ship JC Emery, TW Russell, Y Liu, J Hellewell, CAB Pearson, GM Knight, ... Elife 9, e58699, 2020	117	2020
Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose JP Garnett, EH Baker, S Naik, JA Lindsay, GM Knight, S Gill, JS Tregoning, ... Thorax 68 (9), 835-845, 2013	117	2013
Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines RC Harris, T Sumner, GM Knight, RG White Human vaccines & immunotherapeutics 12 (11), 2813-2832, 2016	112	2016
Implication of backward contact tracing in the presence of overdispersed transmission in COVID-19 outbreaks A Endo, QJ Leclerc, GM Knight, GF Medley, KE Atkins, S Funk, ... Wellcome open research 5, 2020	104	2020
Definition of a genetic relatedness cutoff to exclude recent transmission of meticillin-resistant Staphylococcus aureus: a genomic epidemiology analysis F Coll, KE Raven, GM Knight, B Blane, EM Harrison, D Leek, DA Enoch, ... The Lancet Microbe 1 (8), e328-e335, 2020	97	2020
Bridging the gap between evidence and policy for infectious diseases: How models can aid public health decision-making GM Knight, NJ Dharan, GJ Fox, N Stennis, A Zwerling, R Khurana, ... International journal of infectious diseases 42, 17-23, 2016	89	2016
The health and cost burden of antibiotic resistant and susceptible Escherichia coli bacteraemia in the English hospital setting: A national retrospective cohort study NR Naylor, KB Pouwels, R Hope, N Green, KL Henderson, GM Knight, ... PloS one 14 (9), e0221944, 2019	77	2019
Within-host diversity of MRSA antimicrobial resistances KI Stanczak-Mrozek, A Manne, GM Knight, K Gould, AA Witney, ... Journal of Antimicrobial Chemotherapy 70 (8), 2191-2198, 2015	64	2015
The distribution of fitness costs of resistance-conferring mutations is a key determinant for the future burden of drug-resistant tuberculosis: a model-based analysis GM Knight, C Colijn, S Shrestha, M Fofana, F Cobelens, RG White, ... Clinical Infectious Diseases 61 (suppl_3), S147-S154, 2015	62	2015
Mathematical modelling to study the horizontal transfer of antimicrobial resistance genes in bacteria: current state of the field and recommendations QJ Leclerc, JA Lindsay, GM Knight Journal of the royal society interface 16 (157), 20190260, 2019	59	2019
Potential impact of tuberculosis vaccines in China, South Africa, and India RC Harris, T Sumner, GM Knight, H Zhang, RG White Science translational medicine 12 (564), eaax4607, 2020	54	2020

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors